Alendronate increases bone mineral density in long-term renal transplant recipients

Transplant Proc. 2002 Sep;34(6):2111-3. doi: 10.1016/s0041-1345(02)02872-5.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Controlled Clinical Trial

MeSH terms

  • Absorptiometry, Photon
  • Adult
  • Alendronate / therapeutic use*
  • Bone Density / drug effects*
  • Calcitriol / therapeutic use*
  • Drug Therapy, Combination
  • Female
  • Follow-Up Studies
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Kidney Transplantation / adverse effects
  • Kidney Transplantation / physiology*
  • Male
  • Postoperative Complications / surgery
  • Reoperation
  • Time Factors
  • Treatment Failure

Substances

  • Immunosuppressive Agents
  • Calcitriol
  • Alendronate